Obermeyer Wood Investment Counsel, Lllp Amgen Inc Transaction History

Obermeyer Wood Investment Counsel, Lllp

$1.8 Billion
Q1 2025

A detailed history of Obermeyer Wood Investment Counsel, Lllp transactions in Amgen Inc stock. As of the latest transaction made, Obermeyer Wood Investment Counsel, Lllp holds 4,529 shares of AMGN stock, worth $1.26 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,529

Previous 4,289 5.6%

Holding current value

$1.26 Million

Previous $1.12 Million 26.32%

% of portfolio

0.08%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	BUY	$258.59 - $327.36 $62,061 - $78,566	240 Added 5.6%	4,529 $1.41 Million
Q4 2024 Feb 13, 2025	BUY	$258.78 - $328.31 $14,750 - $18,713	57 Added 1.35%	4,289 $1.12 Million
Q3 2024 Nov 05, 2024	BUY	$309.38 - $337.38 $28,772 - $31,376	93 Added 2.25%	4,232 $1.36 Million
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $14,188 - $17,242	54 Added 1.32%	4,139 $1.29 Million
Q1 2024 May 06, 2024	SELL	$268.87 - $324.56 $537 - $649	-2 Reduced 0.05%	4,085 $1.16 Million
Q4 2023 Jan 31, 2024	BUY	$255.7 - $288.46 $43,213 - $48,749	169 Added 4.31%	4,087 $1.18 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $241,608 - $299,963	1,105 Added 39.28%	3,918 $1.05 Million
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $23,569 - $27,870	-110 Reduced 3.76%	2,813 $624,000
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $8,128 - $9,907	-36 Reduced 1.22%	2,923 $706,000
Q3 2022 Dec 09, 2022	BUY	$224.46 - $253.15 $8,529 - $9,619	38 Added 1.3%	2,959 $667,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $25,378 - $28,241	110 Added 3.91%	2,921 $711,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $113,801 - $125,893	-519 Reduced 15.59%	2,811 $680,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $464,679 - $541,508	2,094 Added 169.42%	3,330 $829,000
Q4 2020 Feb 03, 2021	SELL	$216.38 - $257.67 $32,889 - $39,165	-152 Reduced 10.95%	1,236 $284,000
Q3 2020 Oct 22, 2020	SELL	$234.65 - $260.95 $70,395 - $78,285	-300 Reduced 17.77%	1,388 $353,000
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $11,472 - $14,078	-58 Reduced 3.32%	1,688 $398,000
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $50,662 - $67,192	-278 Reduced 13.74%	1,746 $354,000
Q4 2019 Feb 03, 2020	BUY	$189.21 - $243.2 $2,838 - $3,648	15 Added 0.75%	2,024 $488,000
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $50,666 - $60,708	-291 Reduced 12.65%	2,009 $389,000
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $33,340 - $39,082	-200 Reduced 8.0%	2,300 $424,000
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $37,058 - $41,778	200 Added 8.7%	2,500 $518,000
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $286,436 - $321,729	-1,725 Reduced 42.86%	2,300 $425,000
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $73,871 - $86,328	-436 Reduced 9.77%	4,025 $686,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $12,152 - $13,578	72 Added 1.64%	4,461 $776,000
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $734,235 - $838,299	4,389	4,389 $818,000

Others Institutions Holding AMGN

# of Institutions

3,311

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $148B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Obermeyer Wood Investment Counsel, Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Obermeyer Wood Investment Counsel, Lllp with notifications on news.

Account

Obermeyer Wood Investment Counsel, Lllp Amgen Inc Transaction History